These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 18138367)

  • 21. Observations on the handling of bovine prothrombin and thrombin.
    STEICHELE DF; MAMMEN EF; HATTA Y; SEEGERS WH
    Thromb Diath Haemorrh; 1960 Jun; 4():365-8. PubMed ID: 13834058
    [No Abstract]   [Full Text] [Related]  

  • 22. BLOOD COAGULATION: PRACTICAL SIGNIFICANCE OF RECENT ADVANCES IN KNOWLEDGE OF PROTHROMBIN.
    SEEGERS WH
    Tex State J Med; 1963 Nov; 59():1068-75. PubMed ID: 14084901
    [No Abstract]   [Full Text] [Related]  

  • 23. A factor in serum which accelerates the conversion of prothrombin to thrombin; its evolution with special reference to the influence of conditions which affect blood coagulation.
    ALEXANDER B; DE VRIES A; GOLDSTEIN R
    Blood; 1949 Jun; 4(6):739-46. PubMed ID: 18129759
    [No Abstract]   [Full Text] [Related]  

  • 24. Activation of prothrombin with thrombin.
    FUKUTAKE K; CHO MH; SEEGERS WH
    Am J Physiol; 1958 Aug; 194(2):280-4. PubMed ID: 13559463
    [No Abstract]   [Full Text] [Related]  

  • 25. A factor in serum which accelerates the conversion of prothrombin to thrombin; its determination and some physiologic and biochemical properties.
    DE VRIES A; ALEXANDER B; GOLDSTEIN R
    Blood; 1949 Mar; 4(3):247-58. PubMed ID: 18110687
    [No Abstract]   [Full Text] [Related]  

  • 26. [DISTURBANCES IN THE CHAIN-REACTION OF THROMBIN FORMATION CAUSING HEMORRHAGIC DIATHESIS].
    KOWARZYK H
    Z Gesamte Inn Med; 1965 Feb; 20():SUPPL:273 F. PubMed ID: 14264681
    [No Abstract]   [Full Text] [Related]  

  • 27. [Fluctuations in the level of prothrombin, thrombin, free heparin and the activity of thromboplastin in the blood of patients after surgery on the organs of the intestinal cavity].
    PANAKHIAN AG
    Khirurgiia (Mosk); 1960 May; 36():113-9. PubMed ID: 14430077
    [No Abstract]   [Full Text] [Related]  

  • 28. [DISTURBANCES IN THE CHAIN-REACTION OF THROMBIN FORMATION AS A CAUSE OF HEMORRHAGIC DIATHESIS].
    KOWARZYK H
    Z Gesamte Inn Med; 1965 Feb; 20():SUPPL:269-72 C. PubMed ID: 14270015
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of thrombin on rate of prothrombin conversion.
    THERRIAULT DG; GRAY JL; JENSEN H
    Proc Soc Exp Biol Med; 1957 Jun; 95(2):207-11. PubMed ID: 13441686
    [No Abstract]   [Full Text] [Related]  

  • 30. INHIBITION OF PROTHROMBIN, THROMBIN AND AUTOPROTHROMBIN C WITH ENZYME INHIBITORS.
    CALDWELL MJ; SEEGERS WH
    Thromb Diath Haemorrh; 1965 Jun; 13():373-86. PubMed ID: 14347861
    [No Abstract]   [Full Text] [Related]  

  • 31. [Coagulant and anticoagulant therapy].
    CROIZAT P
    J Med Lyon; 1950 Jul; 31(732):537-45. PubMed ID: 15428798
    [No Abstract]   [Full Text] [Related]  

  • 32. Production of an inactive derivative of purified prothrombin by means of purified thrombin.
    SEEGERS WH; McCLAUGHRY RI
    Proc Soc Exp Biol Med; 1949 Oct; 72(1):247-9. PubMed ID: 15391728
    [No Abstract]   [Full Text] [Related]  

  • 33. Terminal amino acids of bovine prothrombin and thrombin preparations.
    THOMAS WR; SEEGERS WH
    Biochim Biophys Acta; 1960 Aug; 42():556-7. PubMed ID: 13776541
    [No Abstract]   [Full Text] [Related]  

  • 34. Thrombin formation and yield in shed blood in relation to thromboplastins and prothromboplastins.
    FANTL P
    Aust J Exp Biol Med Sci; 1954 Dec; 32(6):853-66. PubMed ID: 14363059
    [No Abstract]   [Full Text] [Related]  

  • 35. [APROPOS OF THE INHIBITOR ROLE OF A PHOSPHOINOSITIDE-TYPE LIPOID ON PROTHROMBIN CONVERSION INTO THROMBIN].
    KAHN M; BOURGAIN R
    Arch Int Pharmacodyn Ther; 1964 May; 149():285-9. PubMed ID: 14169893
    [No Abstract]   [Full Text] [Related]  

  • 36. [Immunological and hemocoagulative characteristics of serums of rabbits immunized with prothrombin, fibrinolysin (plasmin), fibrinogen and thrombin. (Experimental immuno-coagulopathy)].
    DE NICOLA P; ZANGAGLIA O; SOARDI F
    Riv Emoter Immunoematol; 1959; 6():161-78. PubMed ID: 13814944
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prothrombin and its derivatives].
    ULUTIN ON
    Turk Tip Cemiy Mecm; 1962 May; 28():242-7. PubMed ID: 13923737
    [No Abstract]   [Full Text] [Related]  

  • 38. Observations on the conversion of prothrombin to thrombin.
    MANN FD; HURN M; MAGATH TB
    Proc Soc Exp Biol Med; 1947 Oct; 66(1):33-5. PubMed ID: 20270664
    [No Abstract]   [Full Text] [Related]  

  • 39. Kinetics of conversion of prothrombin to thrombin by biological activators. I. Demonstration of a prothrombin derivative which reacts with proteolytic enzyme inhibitors.
    SHYLMAN NR; HEARON JZ
    J Biol Chem; 1963 Jan; 238():155-64. PubMed ID: 13988838
    [No Abstract]   [Full Text] [Related]  

  • 40. Purification of prothrombin and thrombin.
    SEEGERS WH; WARE AG
    Fed Proc; 1948 Mar; 7(1 Pt 1):186. PubMed ID: 18938805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.